Category - Latest Science

GHP News Latest Science

Current status of global polio eradication (June 2025)

The world stands at a critical juncture in the fight against polio. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, polio cases have been reduced by over 99.9%, saving millions from paralysis...

4 June, 2025

3 min read

New vaccine strategy could mean one-and-done for most viruses, rather than endless annual boosters targeting different viral strains. Credit: Aleya Spielman/UCLA Health

GHP News Latest Science

Moderna faces new hurdles as vaccine policy shifts

Moderna, once celebrated for its rapid development of a lifesaving COVID-19 vaccine during the initial Trump administration, now finds itself navigating a dramatically changed landscape as the U.S. government tightens...

4 June, 2025

2 min read

GHP News Latest Science

Breakthrough trans-amplifying mRNA vaccine promises broad, efficient COVID-19 immunity

A study published by Gontu et al. offers a powerful proof-of-concept for a next-generation mRNA vaccine platform that combines dose efficiency, cross-variant protection, and modular design. If validated in clinical...

4 June, 2025

4 min read

GHP News Latest Science

Moderna voluntarily withdraws BLA for Flu/COVID combination vaccine, plans resubmission later in 2025

On May 21, 2025, Moderna, announced a significant update regarding its flu/COVID combination vaccine candidate, mRNA-1083. In consultation with the U.S. Food and Drug Administration (FDA), Moderna has voluntarily...

27 May, 2025

2 min read

GHP News Latest Science

Novavax COVID-19 vaccine gains FDA approval for at-risk populations: Key details for clinicians and researchers

Novavax announced a significant regulatory milestone: the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid™, its recombinant protein-based, non-mRNA COVID-19...

27 May, 2025

3 min read

GHP News Latest Science

FDA, EMA and WHO guidance on updating COVID-19 vaccines for winter 2025/26

As the northern hemisphere prepares for the 2025/26 respiratory virus season, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as well as the World Health Organization (WHO)...

27 May, 2025

4 min read

GHP News Latest Science

The future of protein-based vaccines: Why mRNA is transforming the landscape, but all platforms remain essential

The rapid evolution of vaccine technology, driven by the unprecedented success of mRNA platforms during the COVID-19 pandemic, has fundamentally shifted our approach to protein-based vaccines. mRNA vaccines offer a...

27 May, 2025

4 min read

GHP News Latest Science

The WHO Pandemic Agreement:
A defining moment, if we seize it

On May 20, 2025, the World Health Assembly adopted the first-ever WHO Pandemic Agreement, a decision that many are hailing as a milestone for global health diplomacy. Framed as a response to the failures laid bare by...

22 May, 2025

5 min read

Latest Science

BioNTech R&D escapes to
London – a wake up call

In its press release, BioNTech confirmed it will invest up to £1 billion (about €1.2 billion) over the next ten years to expand its research and development activities for innovative medicines in the United Kingdom. The...

22 May, 2025

2 min read

GHP News Latest Science

Revolutionizing immunization: MIT engineers develop microparticles for time-release vaccines

In a breakthrough that could transform global immunization strategies, engineers at the Massachusetts Institute of Technology (MIT) have developed biodegradable microparticles capable of delivering multiple vaccine...

16 May, 2025

4 min read